NEWLY DIAGNOSED
VIDEO LIBRARIES
In these videos, Dr. Levavi discusses what blastic plasmacytoid dendritic cell neoplasm (BPDCN) is, why people get it, how frequent the disease is...
In these videos, Dr. Levavi discusses what blastic plasmacytoid dendritic cell neoplasm (BPDCN) is, why people get it, how frequent the disease is...
In these videos, Dr. Autumn Starnes gives an overview of melanoma's prevalence and risk factors. She also discusses the ABCDE method of self-screening...
In this video, GRACE provides an overview of Tumor Treating Fields, a wearable device that may be used to treat mesothelioma and glioblastoma...
In these videos, Dr. Mansoor Mirza discusses how endometrial cancer treatment has changed in the past decade, adjuvant radiotherapy for patients with...
ARTICLES
Las biopsias líquidas están revolucionando la forma en que combatimos el cáncer, ofreciendo un futuro donde la detección y el tratamiento son más rápidos, precisos y menos invasivos.
The journey to conquer lung cancer is paved with scientific discovery, and the identification of the EGFR and ALK genes as crucial players marks a significant milestone. Unraveling how mutations in these seemingly small segments of our DNA can unleash the destructive force of cancer has opened up exciting new therapeutic avenues. This exploration delves into the cutting-edge world of EGFR and ALK-targeted therapies, highlighting the progress made and the ongoing quest for even more effective and personalized strategies to combat this formidable disease.
View the full ON-Demand Video now! This live, virtual, interactive patient education event included presentations and panel discussions covering...
COMMUNITY FORUM
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.